Fertility Support Tablet Franchise in Ahmedabad

Women Health Medicine Supplier in Mumbai

Gynecology Medicine Distributor in Delhi

DHEA Tablet Manufacturer in Bangalore

Fertility Tablet Stockist in Hyderabad
Gynecology Tablet Exporter in Chandigarh

Home/Products /dehydroepiandrosterone-micronized-methyl-folate-1mg-vitamin-d3-tablet

Ovaflip D3 Tablet

Composition : Dehydroepiandrosterone (Micronized) (75mg) + L-Methyl Folate (1mg) + Vitamin D3 (2000IU) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹1/-

Ovaflip D3 Tablet containing Dehydroepiandrosterone, L-Methyl Folate, and Vitamin D3 is used for supporting female reproductive health and fertility. It helps in maintaining hormonal balance and improving overall reproductive function.

Dehydroepiandrosterone (DHEA) supports hormonal regulation, L-Methyl Folate aids in proper cell function and reproductive health, while Vitamin D3 contributes to hormonal balance and metabolic support. This combination helps in enhancing fertility outcomes and overall well-being.

The tablet is widely recommended in gynecology practice for fertility support and hormonal health, leading to steady demand and repeat usage in women’s health care.

With increasing awareness about fertility and reproductive wellness, this product offers strong business potential for retailers and distributors. Its growing demand, repeat consumption pattern, and expanding market acceptance make it a valuable product for consistent sales and growth in the gynecology segment.

Read More

About the Product

Ovaflip D3 Tablet containing Dehydroepiandrosterone, L-Methyl Folate, and Vitamin D3 is used for supporting female reproductive health and fertility. It helps in maintaining hormonal balance and improving overall reproductive function.

Dehydroepiandrosterone (DHEA) supports hormonal regulation, L-Methyl Folate aids in proper cell function and reproductive health, while Vitamin D3 contributes to hormonal balance and metabolic support. This combination helps in enhancing fertility outcomes and overall well-being.

The tablet is widely recommended in gynecology practice for fertility support and hormonal health, leading to steady demand and repeat usage in women’s health care.

With increasing awareness about fertility and reproductive wellness, this product offers strong business potential for retailers and distributors. Its growing demand, repeat consumption pattern, and expanding market acceptance make it a valuable product for consistent sales and growth in the gynecology segment.

Some individuals may experience mild acne, oily skin, hair changes, or gastrointestinal discomfort. Rarely, hormonal imbalance-related effects may occur and should be monitored under medical supervision.

Ovaflip D3 Tablet is indicated for women with hormonal imbalance, reduced ovarian reserve, or fertility concerns such as in cases of polycystic ovarian syndrome (PCOS) or assisted reproductive treatments. It helps regulate hormonal levels, support ovulation, improve egg quality, and enhance chances of conception.

This medicine should be used under medical supervision. Hormonal levels should be monitored during therapy. It is not recommended for use without proper evaluation, especially in patients with hormone-sensitive conditions.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation